Valuation: Treace Medical Concepts, Inc.

Market Cap 312M 269M 253M 230M 432M 29.79B 439M 2.96B 1.16B 14.92B 1.17B 1.14B 49.57B P/E 2026 *
-5.63x
P/E 2027 * -6.18x
Enterprise Value 357M 308M 290M 264M 496M 34.15B 504M 3.4B 1.33B 17.1B 1.34B 1.31B 56.84B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.79x
Free-Float
74.51%
Yield 2026 *
-
Yield 2027 * -
1 day+5.99%
1 week+0.42%
Current month+10.90%
1 month+7.90%
3 months+79.70%
6 months+156.99%
Current year+95.10%
1 week 4.46
Extreme 4.46
4.86
1 month 3.85
Extreme 3.85
5.2
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
16.93
5 years 1.17
Extreme 1.17
31.02
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 65 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
8/9/26 Tax

Chief Financial Officer

-37,102 0.0572%
8/9/26 Tax

Responsable ventes & marketing

-9,814 0.0151%
8/9/26 Tax

Compliance Officer

-16,253 0.0251%
Change 5-day change 1-year change 3-year change Capi.($)
+5.99%+0.42%-30.62%-71.67% 312M
+0.08%+0.73%+29.25%+28.03% 12.88B
-0.83%-0.50%+16.32%+28.75% 6.88B
+5.91%+5.29%+52.36%+49.99% 6.46B
+0.65%+2.81% - - 5.66B
+0.14%+4.47%-26.77%+52.53% 4.56B
-1.67%-3.33%-25.92%-23.44% 3.91B
-2.47%+3.42%+44.50%-45.76% 1.97B
-1.98%-1.83%+54.20%-7.08% 1.71B
+1.54%-8.79%-32.53%+136.16% 1.55B
Average +0.74%+0.28%+8.98%+16.39% 4.59B
Weighted average by Cap. +0.59%+1.24%+18.00%+27.74%

Financials

2026 *2027 *
Net sales 207M 179M 168M 153M 288M 19.84B 293M 1.97B 771M 9.93B 779M 762M 33.01B 222M 192M 180M 164M 308M 21.2B 313M 2.11B 824M 10.62B 833M 814M 35.28B
Net income -55.26M -47.73M -44.85M -40.79M -76.69M -5.28B -77.96M -526M -205M -2.65B -207M -203M -8.79B -51.01M -44.06M -41.4M -37.65M -70.79M -4.88B -71.96M -485M -190M -2.44B -192M -187M -8.12B
Net Debt 45.67M 39.44M 37.06M 33.71M 63.37M 4.37B 64.42M 434M 170M 2.19B 171M 168M 7.27B 86.44M 74.66M 70.15M 63.8M 120M 8.27B 122M 822M 321M 4.14B 325M 317M 13.75B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-08-14 US$4.790 +6.21% 245,390
26-08-13 US$4.510 -5.05% 783,912
26-08-12 US$4.750 +0.21% 459,880
26-08-11 US$4.740 +1.50% 472,387
26-08-10 US$4.670 -1.89% 644,139
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.790USD
Average target price
5.500USD
Spread / Average Target
+14.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock